| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.14 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |